Skip to main content
. 2015 Dec 14;8:3721–3730. doi: 10.2147/OTT.S89779

Table 1.

Correlation between NRBP1 and clinicopathological features

Characteristics Patient number (%) NRBP1 low expression (%) NRBP1 high expression (%) P-value
Age (years) 0.296
 <50 49 (53.3) 27 (55.1) 22 (44.9)
 ≥50 43 (46.7) 19 (44.2) 24 (55.8)
Menopausal status 0.053
 Pre-menopausal 35 (38.0) 13 (37.1) 22 (62.9)
 Post-menopausal 57 (62.0) 33 (57.9) 24 (42.1)
Histological grade <0.001
 G1 23 (25.0) 4 (17.4) 19 (82.6)
 G2 38 (41.3) 20 (52.6) 18 (47.4)
 G3 31 (33.7) 22 (71.0) 9 (29.0)
Histological type 0.216
 Ductal 78 (84.8) 42 (53.8) 36 (46.2)
 Lobular 11 (12.0) 3 (27.3) 8 (72.7)
 Others 3 (3.2) 1 (33.3) 2 (66.7)
TNM stage 0.014
 I 16 (17.4) 3 (18.8) 13 (81.2)
 II 21 (22.8) 10 (47.6) 11 (52.4)
 III + IV 55 (59.8) 33 (60.0) 22 (40.0)
Tumor diameter (cm) 0.007
 <2 49 (17.4) 18 (36.7) 31 (63.3)
 ≥2 43 (82.6) 28 (65.1) 15 (34.9)
Nodal status 0.029
 Negative 32 (34.8) 11 (34.4) 21 (65.6)
 Positive 60 (65.2) 35 (58.3) 25 (41.7)
Recurrence 0.004
 No 68 (74.0) 28 (41.2) 40 (58.8)
 Yes 24 (26.0) 18 (75.0) 6 (25.0)

Abbreviations: G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; NRBP1, nuclear receptor binding protein 1; TNM, tumor, node, and metastasis system.